Indu Subaiya, MD, MBA
President, Etude Scientific
Indu Subaiya has worked with a wide range of life-science and healthcare companies helping to translate innovative ideas and early-stage technologies into market realities.
Prior to founding Etude Scientific, Indu served as Vice President of Healthcare and Biomedical Research at Gerson Lehrman Group where she facilitated due diligence research in the life sciences sector for investment fund managers and as Director of Outcomes Research at Quorum Consulting, Inc. where she conducted Phase III-IV quality of life and pharmacoeconomic studies and advised clients on commercialization and reimbursement strategies for novel drugs, medical devices and diagnostic tests.
Indu received her MD from Stony Brook University School of Medicine, an MBA from the Haas School of Business at the University of California, Berkeley, and a BS in Science and Technology from Cornell University.
Indu Subaiya has worked with a wide range of life-science and healthcare companies helping to translate innovative ideas and early-stage technologies into market realities.
Prior to founding Etude Scientific, Indu served as Vice President of Healthcare and Biomedical Research at Gerson Lehrman Group where she facilitated due diligence research in the life sciences sector for investment fund managers and as Director of Outcomes Research at Quorum Consulting, Inc. where she conducted Phase III-IV quality of life and pharmacoeconomic studies and advised clients on commercialization and reimbursement strategies for novel drugs, medical devices and diagnostic tests.
Indu received her MD from Stony Brook University School of Medicine, an MBA from the Haas School of Business at the University of California, Berkeley, and a BS in Science and Technology from Cornell University.